InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,738.17
(
-0.13%
)
US TECH 100
19,436.00
(
-0.73%
)
Dow Jones
42,313.00
(
0.33%
)
Brent Oil
72.61
(
1.26%
)
Bitcoin
64,466.51
(
-1.77%
)
Post# of 253252
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120509
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Jonathan Robinson post# 33201

Monday, 08/28/2006 9:30:03 PM

Monday, August 28, 2006 9:30:03 PM

Post# of 253252
NBIX – If your assertion about the timing of the FDA meetings is correct (as I’m sure it is), I would say the company’s scheduling of the option re-pricing on Sep 26 makes the odds against good news from the FDA meetings overwhelming. This is as strong a harbinger of the outcome of an FDA meeting as I’ve seen in a long while.

By the way, I assume that top management will take care of itself too in due course. As you know, timing option grants to follow bad news is not a securities violation (although perhaps it ought to be). Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up